Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection

 

 Permissions and Reprints

Abstract

Background and study aims Patients receiving antithrombotic drugs have a higher risk of postoperative bleeding and thromboembolic events related to endoscopic procedures. The aim of this study was to evaluate the relationship between various antithrombotic therapies and bleeding after gastric endoscopic submucosal dissection (ESD) (post-ESD bleeding).

Patients and methods Among 529 consecutive gastric ESD procedures (483 patients with 579 legions), 100 patients with 121 lesions who underwent 108 procedures were on antithrombotic therapy (group A) and 382 patients with 458 lesions who underwent 421 procedures were not on antithrombotic therapy (group B). The ratio of post-ESD bleeding between the two groups and the bleeding risk related to various antithrombotic therapies were investigated.

Results Postoperative bleeding was more frequent in group A (11.1 %) than in group B (3.3 %). No thromboembolic events were reported in either group. Further investigation of antithrombotic therapies in group A demonstrated that various combinations of antithrombotic agents and heparin replacement were associated with a higher ratio of post-ESD bleeding. Multivariate analyses revealed that dual antiplatelet therapy (odds ratio [OR] 10.9, 95 % confidence interval [CI] 2.1 – 49.5; P = 0.005) and heparin replacement (OR 34.4, 95 %CI 9.4 – 133.2; P < 0.001) were associated with the increased risk of post-ESD bleeding. In patients on antiplatelet therapy, post-ESD bleeding tended to occur in the early postoperative period compared with patients on anticoagulant therapy.

Conclusions It is necessary to be cautious regarding post-ESD bleeding in patients requiring antithrombotic therapy, especially patients receiving dual antiplatelet therapy and heparin replacement. A further prospective study with a large sample will be needed to confirm these findings.

• References

• 1 Bhatt DL, Scheiman J, Abraham NS. et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 118: 1894-1909
  CrossrefPubMedGoogle Scholar
• 2 Becker RC, Scheiman J, Dauerman HL. et al. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol 2009; 54: 2261-2276
  CrossrefPubMedGoogle Scholar
• 3 Ono H, Kondo H, Gotoda T. et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48: 225-229
  CrossrefPubMedGoogle Scholar
• 4 Abe N, Yamaguchi Y, Takeuchi H. et al. Key factors for successful en bloc endoscopic submucosal dissection of early stage gastric cancer using an insulation-tipped diathermic knife. Hepatogastroenterology 2006; 53: 639-642
  PubMedGoogle Scholar
• 5 Oda I, Saito D, Tada M. et al. A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 2006; 9: 262-270
  CrossrefPubMedGoogle Scholar
• 6 Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer 2007; 10: 1-11
  CrossrefPubMedGoogle Scholar
• 7 Kim BJ, Chang TH, Kim JJ. et al. Efficacy and safety of endoscopic submucosal dissection for early gastric cancer in patients with comorbid diseases. Gut Liver 2010; 4: 186-191
  CrossrefPubMedGoogle Scholar
• 8 Uedo N, Takeuchi Y, Yamada T. et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol 2007; 102: 1610-1616
  CrossrefPubMedGoogle Scholar
• 9 Yang Z, Wu Q, Liu Z. et al. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion 2011; 84: 315-320
  CrossrefPubMedGoogle Scholar
• 10 Ono H, Yao K, Fujishiro M. et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 2016; 28: 3-15
  CrossrefPubMedGoogle Scholar
• 11 Kataoka Y, Tsuji Y, Sakaguchi Y. et al. Bleeding after endoscopic submucosal dissection: Risk factors and preventive methods. World J Gastroenterol 2016; 22: 5927-5935
  CrossrefPubMedGoogle Scholar
• 12 Ogoshi K, Kaneko E, Tada M. The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterological Endoscopy [in Japanese] 2005; 47: 2691-2695
  PubMedGoogle Scholar
• 13 [Anonymous] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457
  CrossrefPubMedGoogle Scholar
• 14 Fujimoto K, Fujishiro M, Katou M. et al. The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterological Endoscopy [in Japanese] 2012; 54: 2075-2102
  PubMedGoogle Scholar
• 15 ASGE Standards ofPractice Committee, Anderson MA, Ben-Menachem T. et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009; 70: 1060-1070
  CrossrefPubMedGoogle Scholar
• 16 Fujimoto K, Fujishiro M, Kato M. et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc 2014; 26: 1-14
  Google Scholar
• 17 Veitch AM, Vanbiervliet G, Gershlick AH. et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy 2016; 48: c1
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 ASGE Standards ofPractice Committee, Acosta RD, Abraham NS. et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016; 83: 3-16
  CrossrefPubMedGoogle Scholar
• 19 Tounou S, Morita Y. Gastric and duodenal endoscopic submucosal dissection in patients on aspirin therapy has increased risk of hemorrhage but is feasible. Gastroenterological Endoscopy[in japanese] 2011; 53: 3326-3335
  PubMedGoogle Scholar
• 20 Goto O, Fujishiro M, Kodashima S. et al. A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding. Gastrointest Endosc 2010; 71: 241-248
  CrossrefPubMedGoogle Scholar
• 21 Igarashi K, Takizawa K, Kakushima N. et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection?. Surg Endosc 2016; DOI: 10.1007/s00464-016-5167-4.
  CrossrefPubMedGoogle Scholar
• 22 Shindo Y, Matsumoto S, Miyatani H. et al. Risk factors for postoperative bleeding after gastric endoscopic submucosal dissection in patients under antithrombotics. World J Gastrointest Endosc 2016; 8: 349-356
  CrossrefPubMedGoogle Scholar
• 23 Furuhata T, Kaise M, Hoteya S. et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy. Gastric Cancer 2017; 20: 207-214
  CrossrefPubMedGoogle Scholar
• 24 Gotoda T, Yanagisawa A, Sasako M. et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-225
  CrossrefPubMedGoogle Scholar
• 25 Takeuchi T, Ota K, Harada S. et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol 2013; 13: 136
  CrossrefPubMedGoogle Scholar
• 26 Matsumura T, Arai M, Maruoka D. et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol 2014; 14: 172
  CrossrefPubMedGoogle Scholar
• 27 Cho SJ, Choi IJ, Kim CG. et al. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 2012; 44: 114-121
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Lim JH, Kim SG, Kim JW. et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms?. Gastrointest Endosc 2012; 75: 719-727
  CrossrefPubMedGoogle Scholar
• 29 Steinberg BA, Peterson ED, Kim S. et al. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation 2015; 131: 488-494
  CrossrefPubMedGoogle Scholar
• 30 Douketis JD, Spyropoulos AC, Kaatz S. et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 2015; 373: 823-833
  CrossrefPubMedGoogle Scholar
• 31 Yoshio T, Nishida T, Hayashi Y. et al. Clinical problems with antithrombotic therapy for endoscopic submucosal dissection for gastric neoplasms. World J Gastrointest Endosc 2016; 8: 756-762
  CrossrefPubMedGoogle Scholar
• 32 Mannen K, Tsunada S, Hara M. et al. Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesions. J Gastroenterol 2010; 45: 30-36
  CrossrefPubMedGoogle Scholar
• 33 Okada K, Yamamoto Y, Kasuga A. et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc 2011; 25: 98-107
  CrossrefPubMedGoogle Scholar
• 34 Ono S, Fujishiro M, Niimi K. et al. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig Liver Dis 2009; 41: 725-728
  CrossrefPubMedGoogle Scholar
• 35 Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 2004; 62: 1187-1189
  CrossrefPubMedGoogle Scholar
• 36 Maulaz AB, Bezerra DC, Michel P. et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62: 1217-1220
  CrossrefPubMedGoogle Scholar
• 37 Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158: 1610-1616
  CrossrefPubMedGoogle Scholar
• 38 Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 2003; 61: 964-968
  CrossrefPubMedGoogle Scholar
• 39 Fukuda H, Yamaguchi N, Isomoto H. et al. Polyglycolic acid felt sealing method for prevention of bleeding related to endoscopic submucosal dissection in patients taking antithrombotic agents. Gastroenterol Res Pract 2016; 2016: 1457357
  PubMedGoogle Scholar